SCHEMBL1190784

SCHEMBL1190784

COc1c(Cl)cc(C(=O)N2CCOc3cnccc32)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 7/20 0.53
SLC22A6 Q4U2R8 1/20 0.53
SLC22A8 Q8TCC7 1/20 0.53
GPBAR1 Q8TDU6 1/20 0.48
POLB P06746 1/20 0.45
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
CCNK O75909 1/20 0.37
CDK12 Q9NYV4 1/20 0.37
IDO1 P14902 1/20 0.37
KCNH2 Q12809 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
LMNA P02545 1/20 0.36
NOTUM Q6P988 1/20 0.36
LCK P06239 1/20 0.36
MET P08581 1/20 0.36
KDR P35968 1/20 0.36
TEK Q02763 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1191465 0.91 SLC22A12 (0.64) SLC22A12SLC22A6SLC22A8GPBAR1POLB
SCHEMBL1191276 0.90 SLC22A12 (0.46) SLC22A12SLC22A6SLC22A8GPBAR1POLB
SCHEMBL1190015 0.88 SLC22A12 (0.62) SLC22A12SLC22A6SLC22A8GPBAR1POLB
SCHEMBL1191293 0.87 SLC22A12 (0.51) SLC22A12SLC22A6SLC22A8GPBAR1POLB
SCHEMBL1191142 0.87 GPBAR1 (0.48) SLC22A12SLC22A6SLC22A8GPBAR1POLB
SCHEMBL1190479 0.86 SLC22A12 (0.63) SLC22A12SLC22A6SLC22A8GPBAR1POLB
Bromide SCHEMBL1190165 0.85 SLC22A12 (0.61) SLC22A12SLC22A6SLC22A8GPBAR1POLB
SCHEMBL4903593 0.84 POLB (0.64) SLC22A12SLC22A6SLC22A8GPBAR1POLB
SCHEMBL1191018 0.82 SLC22A12 (0.55) SLC22A12SLC22A6SLC22A8GPBAR1POLB
SCHEMBL1191290 0.82 SLC22A12 (0.57) SLC22A12SLC22A6SLC22A8GPBAR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2266989-B1 HETEROCYCLIC DERIVATIVES C & C RES LAB (KR) 2015-09-02 EP disclosed
US-8394792-B2 Heterocyclic derivatives C&C RESEARCH LABORATORIES (KR) 2013-03-12 US disclosed
US-20110028467-A1 HETEROCYCLIC DERIVATIVES C&C RESEARCH LABORATORIES (KR) 2011-02-03 US disclosed
EP-2266989-A2 HETEROCYCLIC DERIVATIVES C&c Research Laboratories (KR) 2010-12-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028467-A1 HETEROCYCLIC DERIVATIVES XDH, NUDT1, UGDH SLC22A12 692/4885SLC22A6 625/4885SLC22A8 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.